- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 39/00 - General protective or antinoxious agents
Patent holdings for IPC class A61P 39/00
Total number of patents in this class: 957
10-year publication summary
|
43
|
45
|
71
|
82
|
66
|
103
|
79
|
97
|
99
|
4
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Société des Produits Nestlé S.A. | 9238 |
17 |
| DSM IP Assets B.V. | 5819 |
8 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3038 |
8 |
| The Regents of the University of California | 19493 |
7 |
| Board of Regents, The University of Texas System | 5610 |
7 |
| Peking University | 1232 |
7 |
| Janssen Pharmaceutica N.V. | 3624 |
6 |
| MedImmune Limited | 622 |
6 |
| Orthogen AG | 54 |
6 |
| The Board of Trustees of the Leland Stanford Junior University | 6229 |
5 |
| Aldeyra Therapeutics, Inc. | 108 |
5 |
| Baylor College of Medicine | 918 |
5 |
| Epicentrx, Inc. | 86 |
5 |
| The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. | 363 |
5 |
| Ikaria, Inc. | 12 |
5 |
| Teva Pharmaceuticals Australia Pty Ltd | 30 |
5 |
| Centre National de La Recherche Scientifique | 10068 |
4 |
| The Trustees of the University of Pennsylvania | 4255 |
4 |
| The Australian National University | 189 |
4 |
| The Board of Regents of the University of Oklahoma | 595 |
4 |
| Other owners | 834 |